PerioPal offers unlimited licensing policy for software
PerioPal is now offering a single server, unlimited licensing model for its periodontal charting software. The new option offers similar download and software features as
PerioPal is now offering a single server, unlimited licensing model for its periodontal charting software. The new option offers similar download and software features as
Hygienists and dental therapists would be allowed to administer prescription medicines under a proposal being considered by the U.K. government, according to a story on
The latest version of healthcare reform legislation to come out of the U.S. Congress includes dental coverage for all children, according to the Children’s Dental
U.S. District Judge John Keenan has told the jury in the Merck Fosamax lawsuit case in New York to keep deliberating, despite the panel’s claim
One of the world’s largest dental laboratories is moving into the U.S., following a merger that will operate under the name Modern Dental Laboratory USA,
Despite the economic recession, tooth loss among the elderly will create some growth in the $3 billion global dental implant market, according to Kalorama Information’s
GlaxoSmithKline has introduced a new toothpaste delivery system that disperses active ingredients quickly, penetrating hard-to-reach areas of the mouth, according to the company. Iso-active, which
The British Society of Paediatric Dentistry is urging dentists to look for signs that children are neglected or abused. Dental neglect can suggest a wider
Violight recently announced that an independent laboratory test has proved that its Violight toothbrush sanitizer to be effective in virtually eliminating the H1N1 flu virus
Milestone Scientific, which makes computerized injection equipment, has announced that Leslie Bernhard, an independent director, has been named chairman of the board. He succeeds Leonard
Is propofol better than sevoflurane as a general anesthesia for pediatric patients? Noting that “volatile anesthetics” have been associated with emergence delirium in children, while
NEW YORK (Reuters), Sep 3 – Jurors heard sharply different closing arguments on Wednesday in a trial over whether or not Merck & Co.’s Fosamax